Skip to main content

Clicks expects up to 13% profit jump

| Retailer trading results

Pharmacy chain Clicks Group said on Thursday it expects its full-year earnings to be up 8% to 13% after reporting a 9.5% rise in half-year earnings, boosted by consumer demand for preventative medicine and new private hospital business.


Reuters | IOL

The forecast for diluted headline earnings per share (HEPS) for the year ending Aug. 31 does not take into account any trading restrictions which may be imposed in response to a possible third wave of COVID-19 infections in the months ahead, Clicks said.

It also does not consider any potential impact from the group's retail and distribution businesses' participation in the national COVID-19 vaccination programme.

"This forecast assumes that the current constrained trading environment will be sustained into the second half of the 2021 financial year and continue to be impacted by COVID-19," the company said.

In the six months to Feb. 28, diluted HEPS rose to 371 cents. Further gains were hampered by the impact of the closure of its Musica entertainment business.

HEPS is a measure of profit used for companies in South Africa.

Group turnover increased by 7.6% to 18.1 billion rand ($1.27 billion) as retail health and beauty sales grew by 7.2%, supported by strong front shop health sales growth of 24.7% as customers focused on wellness and immune boosting vitamins and supplements.

Customers working from home and wearing masks has meant lower demand for beauty products like makeup and fragrances and accessories, but skin care performed well, chief executive Vikesh Ramsunder said, as the constant wearing of masks introduced acne for some people.

Turnover was also boosted by its healthcare wholesaler and distributor, United Pharmaceutical Distributors (UPD), which grew turnover by 9% and continued to gain market share, driven by the robust growth in the hospital channel during the pandemic and by attracting new wholesale business.

UPD has bid for a tender to distribute and store COVID-19 vaccines under the country's second phase of the rollout, which is expected to start on May 17. Successful bidders are yet to be announced.

Pin It

Related Articles

By: Bianke Neethling – Daily Investor SPAR experienced a massive drop in profit as the retailer is still dealing with the hangover of system issues in South Africa and inflationary pressures.
By: Drikus Greyling – Daily Investors Last month, Pick n Pay released its results for the year that ended 25 February 2024. They were disastrous.
By: Bianke Neethling – Daily Investor Pick n Pay reported its worst financial results in its listed history last week following years of mismanagement, but its new CEO has a plan to turn the company around.
By: Shaun Jacobs – Daily Investor In a trading statement for the 52-week period that ended 25 February 2024, Pick n Pay said it expects the company to post a loss of between R3.14 billion and R3.38 billion for the 2024 financial year.&n...
By Jacqueline Mackenzie - Business Live The group expects full-year Heps to increase by between 10% and 15%